Gastroenterology is disrupted. It’s time to create a new future. Scope Forward will pave the way for GI practitioners to lead the change.
Ann Arbour, Michigan
Joined July 2020
- Tweets185
- Following8
- Followers9
- Likes3
Scope Forward retweeted
At #DDW2026? Don’t miss this: 🗣️ Meet Praveen Suthrum at AGA Central (West Central Concourse, Level 3)
📆 Saturday, May 2 | 3–4 p.m.
🔗 Ask about GI Mastermind Virtual (self-paced: Digital • Business • Leadership).
ow.ly/ei0350YNAWU
Scope Forward retweeted
#AI is no longer a side initiative in #Gastroenterology.
It’s becoming an operating decision.
In the latest Scope Forward Show episode, leaders from One GI, @100mslive, and @nextservices discuss how AI is reshaping the business model of Gastroenterology.
youtube.com/watch?v=xrXfBYiv…
Scope Forward retweeted
Our new CPU in @AGA_Gastro offers best-practice guidance for inpatient care.
Read more: ow.ly/68HX50Y8tVu
Watch authors discuss how this CPU can improve inpatient care for adults with IBD: ow.ly/KcPm50Y8tTf
@EdwardLoftus2 @JHashashMD @IBDMD @ShirleyCoMekMD
Scope Forward retweeted
🔥 Most-read in January
Our Top 5 stories that sparked conversation and informed practice: linktr.ee/gastroendonews #Gastroenterology
Scope Forward retweeted
NextServices has partnered with One GI and 100ms to accelerate an AI-driven operating model for gastroenterology.
On the upcoming Scope Forward Show, Praveen breaks down how One GI is rethinking operations, technology, and scale.
Watch the teaser: youtube.com/watch?v=BT5bUMgu…
Scope Forward retweeted
NextServices is partnering with OneGI® and 100ms to accelerate an AI-driven operating model for gastroenterology.
AI embedded directly into GI access & admin workflows — built for real operations, not pilots.
Read more: nextservices.com/nextservice…
#Gastroenterology #AIinGI
Scope Forward retweeted
💡 Type matters! Type 1 peripheral SpA parallels IBD activity; Type 2 & axial SpA may be independent. Personalized therapy, sometimes combining advanced IBD drugs with anti-inflammatories, is crucial gastroendonews.com/a/LTMBAA/… #IBD #SpA
Scope Forward retweeted
💰 Talking about money shouldn’t be taboo. At the #ScrubsAndHeels Leadership Summit, Drs. Aline Charabaty & Dawn Sears shared how physicians can protect their assets and build long-term financial security➡️ gastroendonews.com/a/szMBAA/… #WomenInMedicine #PhysicianFinance #Leaders
Scope Forward retweeted
905K views! 🤯🔥
SIBO & IMO: Understanding Gut Overgrowth, Methane, and Archaea
Our latest SIBO episode with @MarkPimentelMD, @CedarsSinai and the @MASTprogram just became the most-watched video in Gastro Girl history.
If you’ve wondered whether symptoms like bloating, gas, abdominal discomfort, constipation, or unpredictable digestion might be tied to SIBO, this episode is a must-watch.
This episode was produced in collaboration with the @AmCollegeGastro Patient Care Committee.
👉 Watch the full episode: youtu.be/SQPwHIzULfQ
#SIBO #GutHealth #IBS #Pimentel
Scope Forward retweeted
#BrainGut therapies are urgently needed as pediatric #IBS and functional abdominal pain disorders reach 12% globally 🌏
🗣️ New ESPGHAN/NASPGHAN guidelines back these as first-line care, note Drs. Kari Baber & Kelly O’Neil Rodriguez @ChildrensPhila.
bit.ly/441w1yz
Scope Forward retweeted
Download the new Scope Forward report — Inside the $9B Gut Economy: How Microbiome Science Is Rewriting Healthcare’s Future.
Link: scopeforward.com/gut-microbi…
#Scopeforward #gut #microbiome
Scope Forward retweeted
Ready to step into your power? Apply for our Women’s Executive Leadership Conference by Dec. 17.
🚨 Gain executive-level leadership skills.
👩⚕️ Expand your network.
💡 Collaborate on real-world solutions.
🔗 Apply now: ow.ly/1LbC50X5838
Scope Forward retweeted
How will #FDA approval for @JNJNews’ #Tremfya SubQ induction change #IBD care?
💡 @IBDMD of @UChicagoMed shares insights on how this SubQ option will “simplify the process” to start patients on induction therapy ➕ pre-authorization from payers.
bit.ly/3VKlPWI
Scope Forward retweeted
📱 Who's leading #GI conversations on #TikTok?
👩⚕️ 66.5% of #ColorectalCancer content came from physicians
🙋 79% of #IBS ➕ 80% of #IBD content came from patients
This comes with “a risk for misleading content,” noted Dr. Alejandro Robles @TexasTech
bit.ly/4gLlo84
Scope Forward retweeted
ACG releases first U.S. guideline on gastric premalignant conditions. Focus: early detection, high-risk surveillance, and improving gastric cancer outcomes. gastroendonews.com/a/HDEBAA/… #Gastroenterology #ACG2025
Scope Forward retweeted
Register for today’s ACG Virtual Grand Rounds:
Dr. Michael Camilleri on GLP-1s and GI Complications: What Every Clinician Needs to Know!
⏰ Noon & 8 pm ET
➡️ gi.org/ACGVGR
Scope Forward retweeted
Our new clinical practice update in @AGA_CGH by authors @AmitPatelDukeMD, @Rex_colonoscopy, and @alerepici offers expert tips on choosing the right one based on resection method, histology, expertise, and cost. Read more here: ow.ly/7C2y50W4ulr
#GItwitter
Scope Forward retweeted
Because GI conditions often include pain as a symptom, pain control is an important part of treatment, but busy GI docs may avoid neuromodulators due to concerns about managing side effects. These agents can be helpful. @JayPasrichaMD
gastroendonews.com/a/Jy0BAA/…
Scope Forward retweeted
Will #AI replace #centralreview in #IBD #clinicaltrials? @sameerkberry and @umfoodoc speak with @CrohnsDoc about ways in which artificial intelligence can revolutionize the conduct of clinical trials in inflammatory bowel disease.
Listen now: healio.com/news/gastroentero…
Scope Forward retweeted
What a turnout by GI psychologists at #DDW2025! 🤩 We always love hosting this fun group at AGA Central. @DrRiehl #gastropsych
